FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Syndicate content

Genvec News

Most Popular Genvec Story

ALSO NOTED: Generic Plavix grabs big market share; Medarex to collaborate on antibodies; and much more...

> The generic version of Plavix has already claimed slightly more than 60 percent of the total market for the drug and 74 percent of all new prescriptions. In court testimony yesterday a financial expert hired by Apotex says that if the generic drug maker loses its fight to continue selling the drug, it would cost the company $4 billion. Report

> Medarex and Germany's GenPat77 Pharmacogenetics will …

... Read more...

Latest Headlines